                         SEQUENCE LISTING

<110>  Apitope International NV
 
<120>  THERAPEUTIC METHOD

<130>  P108819PCT

<150>  GB 1700111.6
<151>  2017-01-04

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Pro Arg His Arg Asp Thr Gly Ile Leu Asp Ser Ile Gly Arg Phe 
1               5                   10                  15  


<210>  2
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  2

Glu Asn Pro Val Val His Phe Phe Lys Asn Ile Val Thr Pro Arg Thr 
1               5                   10                  15      


Pro 
    


<210>  3
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  3

Ala Ser Asp Tyr Lys Ser Ala His Lys Gly Phe Lys Gly Val Asp 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  4

Gly Phe Lys Gly Val Asp Ala Gln Gly Thr Leu Ser Lys Ile Phe 
1               5                   10                  15  


<210>  5
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  5

Lys Lys Lys Lys Tyr Val Ser Ile Asp Val Thr Leu Gln Gln Leu Glu 
1               5                   10                  15      


Ser His Lys Lys Lys 
            20      


<210>  6
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  6

Gly Leu Lys Met Phe Pro Asp Leu Thr Lys Val Tyr Ser Thr Asp 
1               5                   10                  15  


